Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canadian company, which develops barium, iodine and carbon active pharmaceutical ingredients. The Company is focused on producing its own barium, iodine and fullerene minerals. The Company, through its subsidiaries, Voyageur Industrial Minerals Ltd. and Voyageur Minerals Inc., is engaged in acquiring, exploring and developing raw materials for pharmaceutical... see more

Recent & Breaking News (TSXV:VM)

Voyageur Pharmaceuticals Ltd. Files Interim Financial Statements and Grants Deferred Share Units

TheNewsWire April 28, 2023

Voyageur (TSXV:VM) confirms preference for SmoothX in comparative studies

Trevor Abes  April 11, 2023

Voyageur Pharmaceuticals Ltd. Completes Comparative Studies of its SmoothX(R) Contrast Media Confirming Product Superiority, and announces Option Grant and AGM Date

TheNewsWire April 4, 2023

Voyageur Pharmaceuticals Ltd. Files Annual Audited Financial Statements

TheNewsWire March 30, 2023

Voyageur Pharmaceuticals Ltd. Provides an Update and Prepares to Launch Initial Sales in Canada

TheNewsWire February 14, 2023

Voyageur Pharmaceuticals Ltd. Announces Issuance of Shares for Debt

TheNewsWire January 27, 2023

Amended: Voyageur Pharmaceuticals Ltd. Announces Final Closing of Increased Private Placement

TheNewsWire January 23, 2023

Voyageur Pharmaceuticals Ltd. Announces Final Closing of Increased Private Placement

TheNewsWire January 20, 2023

Voyageur Pharmaceuticals (TSXV:VM) upsizes non-brokered private placement

John Ballem  January 13, 2023

Voyageur Pharmaceuticals Ltd. Announces Increase to Private Placement

TheNewsWire January 12, 2023

Voyageur Pharmaceuticals (TSXV:VM) closes first tranche of private placement

Trevor Abes  December 23, 2022

Junior biotech company poised for MAJOR pharma success

Jeff Nielson December 23, 2022

Voyageur Pharmaceuticals Ltd. Announces First Closing of Private Placement

TheNewsWire December 23, 2022

Voyageur Pharmaceuticals (TSXV:VM) introduces SmoothX and announces capital raise

John Ballem  December 12, 2022

Voyageur Pharmaceuticals Ltd. Announces Canadian Launch of SmoothX (TM) Barium Contrast Media & Financing

TheNewsWire December 8, 2022

Voyageur Pharmaceuticals Ltd. Announces Equity Incentive Compensation

Newsfile December 2, 2022

Voyageur (TSXV:VM) completes SmoothX testing

Caroline Egan  November 29, 2022

Voyageur Pharmaceuticals Ltd. Completes Medical Imaging CT Contrast Agent Production Testing and Begins Production Scale-up of SmoothX (TM)

TheNewsWire November 28, 2022

Voyageur announces carbon-capture strategy and upgrade to supply chain

Jeff Nielson November 8, 2022

Voyageur Pharmaceuticals (TSXV:VM) designs carbon neutral pharmaceutical manufacturing plant

John Ballem  November 1, 2022